Acadia Pharmaceuticals Income Statement
ACAD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Acadia Pharmaceuticals reported $1.1B in revenue and $391M in net income for FY2025. Revenue has grown at a 56.3% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $957.8M | $726.4M | $517.2M | $484.1M | $441.8M | $339.1M | $223.8M | $124.9M | $17.3M | $61.0K | $4.9M | $1.1M | $4.9M | $2.1M |
| Cost of Revenue | $89.0M | $81.8M | $41.6M | $10.2M | $19.1M | $10.2M | $11.3M | $12.4M | $9.1M | $3.1M | - | - | - | - | - |
| Gross Profit | - | - | $684.8M | $507.1M | $473.3M | $431.5M | $327.7M | $211.4M | $115.8M | $14.3M | - | - | - | - | - |
| SG&A Expense | $548.9M | $488.4M | $406.6M | $369.1M | $396.0M | $388.7M | $325.6M | $265.8M | $255.1M | $186.5M | $88.3M | $7.0M | $12.7M | $7.0M | $1.1M |
| R&D Expense | $328.8M | $303.2M | $351.6M | $361.6M | $239.4M | $319.1M | $240.4M | $187.2M | $149.2M | $99.3M | $73.9M | $18.8M | $26.7M | $18.8M | $17.3M |
| Operating Income | $104.8M | $230.8M | -$73.4M | -$223.6M | -$170.4M | -$286.6M | -$246.5M | -$247.4M | -$292.4M | -$272.8M | -$164.6M | -$20.9M | -$38.3M | -$20.9M | -$22.9M |
| Income Tax | -$252.1M | $31.6M | $10.3M | $2.5M | $351.0K | $611.0K | $876.0K | $1.3M | $1.1M | $1.3M | $330.0K | $0 | $0 | $0 | $17.0K |
| Net Income | $391.0M | $226.5M | -$61.3M | -$216.0M | -$167.9M | -$281.6M | -$235.3M | -$245.2M | -$289.4M | -$271.4M | -$164.4M | -$20.8M | -$37.9M | -$20.8M | -$22.8M |
| EPS (Basic) | $2.32 | $1.37 | -$0.37 | -$1.34 | -$1.05 | -$1.79 | - | - | - | - | - | - | - | -$0.38 | -$1.20 |
| EPS (Diluted) | $2.30 | $1.36 | -$0.37 | -$1.34 | -$1.05 | -$1.79 | -$1.60 | -$1.94 | -$2.36 | -$2.34 | -$1.63 | -$0.38 | -$0.44 | -$0.38 | -$1.20 |
| Shares Outstanding | 170.3M | 166.7M | 164.7M | 162.1M | 161.0M | 159.6M | 155.3M | 143.9M | 124.4M | 121.4M | 101.9M | 91.1M | 91.1M | 73.3M | 39.4M |
| Gross Margin | - | - | 94.3% | 98.0% | 97.8% | 97.7% | 96.7% | 94.5% | 92.7% | 82.2% | - | - | - | - | - |
| Operating Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -425.6% | -3344.7% | -425.6% | -1105.6% |
| Profit Margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% | -63.7% | -69.4% | -109.6% | -231.7% | -1565.9% | -269578.7% | -424.9% | -3314.2% | -424.9% | -1101.4% |